The Editor’s Roundtable: The 10Q Report—Advancing Women’s Heart Health Through Improved Research, Diagnosis, and Treatment




Acknowledgment


This CME activity is supported by an educational grant from Gilead Sciences , Foster City, California.




Disclosures


Dr. Friedewald has no relevant financial relationships to disclose. Dr. Hayes has no relevant financial relationships to disclose. Dr. Pepine receives grant/research support from Amarin , Bedminster, New Jersey; Amgen , Thousand Oaks, California; Amorcyte , Allendale, New Jersey; Mesoblast , New York, New York; AstraZeneca Pharmaceuticals , Wilmington, Delaware; Baxter Healthcare , Deerfield, Illinois; Cytori Therapeutics , San Diego, California; Daiichi Sankyo , Parsippany, New Jersey; Gambro , Lakewood, Colorado; Genetech , San Francisco, California; GlaxoSmithKline , Philadelphia, Pennsylvania; Eli Lilly , Indianapolis, Indiana; Medtronic , Minneapolis, Minnesota; National Institutes of Health/National Heart Blood and Lung Institute , Bethesda, Maryland; and Sanofi-Aventis , Bridgewater, New Jersey and is a consultant for Amarin, Eli Lilly, Mesoblast, and SLACK, Thorofare, New Jersey. Dr. Roberts has no relevant financial relationships to disclose. Dr. Wenger receives research grants/contracts from and is part of Trial Steering Committee/Trial Adjudication Committee/Trial Data Safety and Monitoring Board of Abbott Laboratories , Abbott Park, Illinois; Gilead Sciences , Foster city, California; Merck , Whitehouse Station, New Jersey; National Heart and Blood Institute, Bethesda, Maryland; and Pfizer, New York, New York and is a consultant for Abbott Women’s Advisory Board, Aboot Park, Illinois; Amgen, Thousand Oaks, California; AstraZeneca, Bridgewater, New Jersey; Gilead Sciences; Janssen, Titusville, New Jersey; Merck; and Pfizer.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Antiplatelet Effect of Thienopyridine ( Clopidogrel or Prasugrel ) Pretreatment in Patients Undergoing Primary Percutaneous Intervention for ST Elevation Myocardial Infarction
  2. Case-Control Registry of Excimer Laser Coronary Angioplasty Versus Distal Protection Devices in Patients With Acute Coronary Syndromes due to Saphenous Vein Graft Disease
  3. Usefulness and Consequences of Cardiac Resynchronization Therapy in Dialysis-Dependent Patients With Heart Failure
  4. Risk Factors for Pericardial Effusion in Native Valve Infective Endocarditis and Its Influence on Outcome

Stay updated, free articles. Join our Telegram channel
Tags:
Dec 5, 2016 | Posted by in CARDIOLOGY | Comments Off on The Editor’s Roundtable: The 10Q Report—Advancing Women’s Heart Health Through Improved Research, Diagnosis, and Treatment

Full access? Get Clinical Tree
Get Clinical Tree app for offline access